Position
Sunpointe, LLC in Gilead Sciences, Inc.
Back to the book · All holders of GILD
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $41.9K$122.74 → $139.37
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 3.38K | $415.1K | — | — | — | 0.1% |
| Q1 2026 | 2.52K | $351.4K | $139.37 | $41.9K | −$105.7K | 0.1% |